Chalasani N - Search Results

1

Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study.

Huang DQ, Wilson LA, Behling C, Amangurbanova M, Kleiner DE, Kowdley KV, Dasarathy S, Terrault NA, Diehl AM, Chalasani N, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J, Loomba R; NASH Clinical Research Network. Huang DQ, et al. Among authors: chalasani n. Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001015. Online ahead of print. Hepatology. 2024. PMID: 39028908

2

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.

Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Unalp A; NASH Clinical Research Network. Chalasani N, et al. J Hepatol. 2008 May;48(5):829-34. doi: 10.1016/j.jhep.2008.01.016. Epub 2008 Feb 12. J Hepatol. 2008. PMID: 18321606 Free PMC article.

3

Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.

Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV; NASH Clinical Research Network. Nelson JE, et al. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1253-1264. doi: 10.1111/apt.13824. Epub 2016 Oct 11. Aliment Pharmacol Ther. 2016. PMID: 27730688 Free PMC article.

4

Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.

Gawrieh S, Lake JE, Debroy P, Sjoquist JA, Robison M, Tann M, Akisik F, Bhamidipalli SS, Saha CK, Zachary K, Robbins GK, Gupta SK, Chung RT, Chalasani N, Corey KE. Gawrieh S, et al. Among authors: chalasani n. Hepatology. 2023 Aug 1;78(2):578-591. doi: 10.1097/HEP.0000000000000313. Epub 2023 Feb 22. Hepatology. 2023. PMID: 36805976 Free PMC article.

5

PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease.

Desai AP, Madathanapalli A, Tang Q, Orman ES, Lammert C, Patidar KR, Nephew LD, Ghabril M, Monahan PO, Chalasani N. Desai AP, et al. Among authors: chalasani n. Hepatology. 2023 Dec 1;78(6):1788-1799. doi: 10.1097/HEP.0000000000000480. Epub 2023 May 25. Hepatology. 2023. PMID: 37222262 Free PMC article.

6

Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease.

Sterling RK, Vilar-Gomez E, Wilson LA, Loomba R, Gawrieh S, Price J, Naggie S, Lake JE, Heath S, Tonascia J, Sulkowski M, Chalasani N; HIV-NASH CRN. Sterling RK, et al. Among authors: chalasani n. Am J Gastroenterol. 2024 Aug 1;119(8):1483-1495. doi: 10.14309/ajg.0000000000002700. Epub 2024 Feb 5. Am J Gastroenterol. 2024. PMID: 38314810

7

Primary Care Screening for Nonalcoholic Fatty Liver Disease Among People With HIV in the United States: A Real-World Provider Survey.

Price JC, Hirose K, Chalasani N, Crandall H, Heath S, Loomba R, Naggie S, Sterling RK, Sulkowski M, Wilson L, Lake JE. Price JC, et al. Among authors: chalasani n. J Assoc Nurses AIDS Care. 2024 Dec 24. doi: 10.1097/JNC.0000000000000505. Online ahead of print. J Assoc Nurses AIDS Care. 2024. PMID: 39718369

8

Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.

Moore MP, Wang X, Kennelly JP, Shi H, Ishino Y, Kano K, Aoki J, Cherubini A, Ronzoni L, Guo X, Chalasani NP, Khalid S, Saleheen D, Mitsche MA, Rotter JI, Yates KP, Valenti L, Kono N, Tontonoz P, Tabas I. Moore MP, et al. Among authors: chalasani np. Hepatology. 2024 May 22. doi: 10.1097/HEP.0000000000000933. Online ahead of print. Hepatology. 2024. PMID: 38776184

9

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study.

Nephew LD, Gupta D, Carter A, Desai AP, Ghabril M, Patidar KR, Orman E, Dziarski A, Chalasani N. Nephew LD, et al. Among authors: chalasani n. Hepatol Commun. 2023 Feb 9;7(3):e0058. doi: 10.1097/HC9.0000000000000058. eCollection 2023 Mar 1. Hepatol Commun. 2023. PMID: 36757397 Free PMC article.

10

Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis.

Patidar KR, Guarnizo Ortiz M, Slaven JE, Nephew LD, Vilar Gomez E, Kettler CD, Ghabril MS, Desai AP, Orman ES, Chalasani N, Gawrieh S. Patidar KR, et al. Among authors: chalasani n. Hepatol Commun. 2023 Dec 7;7(12):e0341. doi: 10.1097/HC9.0000000000000341. eCollection 2023 Dec 1. Hepatol Commun. 2023. PMID: 38055648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters